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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Does
hippotherapy improve gross motor function in children with cerebral palsy?”.
STUDY DESIGN: A systematic review of three randomized controlled trials (RCTs), with one
being a randomized crossover trial. All three were published between 2015 and 2018.
DATA SOURCES: Three RCTs published in peer-reviewed journals were chosen from PubMed.
The studies were selected based on their relevance to the clinical question.
OUTCOMES MEASURED: The outcome measured was improvement in gross motor function.
Either hip adductor spasticity using Modified Ashworth Scale (MAS) or the Gross Motor
Function Measure 66 (GMFM-66) was used to assess the outcomes. Scores were assessed before
and after treatments were conducted.
RESULTS: The statistical analyses used were mean change from baseline and p-values. In the
RCT conducted by Lucena-Antón et al., hippotherapy led to a reduction in hip adductor
spasticity by an average of 0.27 in the left and 0.45 in the right. In the randomized crossover trial
led by Deutz et al., the mean change in GMFM-66 between hippotherapy intervention period and
no hippotherapy period was 2.99 in the early treatment group (ETG) and 1.60 in the late
treatment group (LTG). In the RCT conducted by Kwon et al., the mean change in GMFM-66
from baseline in the hippotherapy group was 2.7. All three studies found a statistically significant
difference between the intervention and the control group with a p-value <0.05.
CONCLUSIONS: All three studies found statistically significant improvement in gross motor
function in the intervention group compared to the control group. The results of this selective
review suggest that hippotherapy is more effective in improving gross motor function in children
with cerebral palsy than conventional physical therapy alone. Further studies should be
conducted in the United States comparing the effectiveness of hippotherapy to the standard
physical therapy administered in the States.
KEY WORDS: hippotherapy and cerebral palsy
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INTRODUCTION
Hippotherapy is equine-assisted therapy for therapeutic or rehabilitation purposes that
focuses on the benefits of improving postural control, balance, and strength. Hippotherapy may
be beneficial for those with conditions such as, cerebral palsy, autism, developmental delay,
stroke, multiple sclerosis and traumatic brain injuries. Cerebral palsy is a group of movement and
posture development disorders that occur during the fetal or infant brain development and is
non-progressive.1 Cerebral palsy is the most common motor disability in children. Between 2 and
2.5/1,000 live births are born with cerebral palsy.1 That is around 10,000 babies born with
cerebral palsy per year in the United States. Having a child with cerebral palsy requires the help
of numerous resources and is financially demanding. In 2019, the annual Medicaid cost per child
with cerebral palsy was $22,383.2 The lifetime cost of an individual with cerebral palsy is
estimated to be nearly $1 million.3 Children with cerebral palsy require the use of many
healthcare services, averaging 23 annual specialized care visits and four emergency services
visits.4
In most cases of cerebral palsy, the exact cause is unknown. Possible causes are genetic
abnormalities, congenital brain malformations, maternal infections or fevers, episodes of fetal or
infant hypoxia. It is non-progressive and there is no cure for cerebral palsy, but medications,
physical therapy and surgeries can help improve motor skills. Cerebral palsy leads to varying
degrees of deficiencies, medical, social and educational implications.1 While some individuals
with cerebral palsy may be able to earn incomes and live independently, many have cognitive
issues which limit them. There are four main types of cerebral palsy classified as - spastic,
dyskinetic, ataxic and mixed. Spastic is the most common type and is due to hypertonia leading
to stiff muscles that are difficult or impossible to move. The increased muscle tone in the hip
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muscles along with the associated sensory deficits, such as poor proprioception and cutaneous
sensation, can lead to poor postural tone and balance.1
Treatment for cerebral palsy is aimed at improving quality of life and gaining the greatest
level of independence possible for the individual. Muscle relaxants such as baclofen, tizanidine,
dantrolene, or diazepam can aid in relieving stiff muscles. Physical therapy can help reduce
muscle tension and allow for greater control of movements. Occupational therapy can teach
techniques in order to independently perform activities of daily living. Speech and language
therapy will assist in language skills such as building vocabulary and grammar. Orthopedic
surgeries, such as tendon release surgery, help to improve mobility. Selective dorsal rhizotomy,
which targets and destroys certain nerve roots, can be done for severe cases of spasticity when
other treatments have failed.
Hippotherapy is an alternative form of physical therapy that is more engaging and
exciting for children with cerebral palsy. The horse’s seat is a dynamic therapeutic tool that
provides three-dimensional impulses to the rider’s neuromuscular system. The three-dimensional
movements of a walking horse stimulates normal pelvic movements that closely mimic those
during ambulation in the rider.6 This allows for development of postural control, improves trunk
strength, control, and balance.1,5 It also addresses weight-bearing shifts and improves motor
planning.6 The head, arms and trunk segment are balanced over the lower limbs, making the hips
the center for balance control. Since spasticity of hip muscles is directly related to hip motion, a
reduction in hip adductor spasticity will cause a gain in postural control and balance.1 This paper
evaluates two randomized controlled trials and one randomized crossover trial evaluating the
efficacy of hippotherapy for gross motor function improvement in children with cerebral palsy.
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OBJECTIVE
The objective of this selective EBM review is to determine whether or not “Does
hippotherapy improve gross motor function in children with cerebral palsy?”.
METHODS
Studies were chosen through PubMed and selected based on if they answered a clinically
relevant question and if it included a patient-oriented outcome. The studies were also chosen
based on inclusion and exclusion criteria. The study had to be a randomized control trial
published in 2011 or later, with a study population consisting of children with cerebral palsy.
Any studies that were simulations or published prior to 2011 were excluded. The keywords that
were used in searches were “hippotherapy” and “cerebral palsy”. All articles were published in
peer reviewed journals and published in English. The statistical analysis used in these studies
were mean change from baseline as well as assessing statistical significance using p-values
(significance level set to <0.05).
The population being studied includes children with cerebral palsy. The specific
demographics of each study selected can be found below in Table 1. A comparison between
hippotherapy along with conventional physical therapy to a control group receiving conventional
physical therapy alone or with aerobic home therapy was investigated. The outcome measured
was improvement in gross motor function. The types of studies chosen were two RCTs and one
randomized control crossover trial.
OUTCOMES MEASURED
The outcome measured was improvement in gross motor function. In the study conducted
by Lucena-Antón et al., hip adductor spasticity was measured using Modified Ashworth Scale
(MAS).1 The MAS score is the most widely used scale to assess muscle hypertonia.1 It uses the
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Table 1. Demographics and Characteristics of Included Studies
Study

Type

#
Pts

Age
(Years)

Inclusion Criteria

Exclusion Criteria

W/
D

Interventions

LucenaAntón1
(2018)

RCT

44

3-14

Prior diagnosis of
spastic CP,
non-walking children
GMFCS levels: IV-V,
and children aged 3 to
14 years

Children
treated with botulinum
toxin or surgery within
6 months.

0

Hippotherapy
once a week for
45 min for 12
consecutive
weeks along with
conventional
therapy vs
control group:
conventional
physical therapy
alone.

Deutz5
(2018)

Random
ized
crossov
er trial

73

5-16

Bilateral spastic CP,
5-16 years old, no HT
and no major
surgery during the
preceding 12 months,
no allergy to horse
hair, informed consent
of the parents, GMFCS
II to IV, and no
achillotenotomy
performed during the
preceding 6 months.

Profound mental
retardation with
absence of
basal communication
skills, fear of horses,
botulinum toxin
therapy or major
surgery intended to
start during the study
period.

19

16-20 weeks of
hippotherapy
along with
conventional
physical therapy
in the early and
late treatment
groups vs
16-20 weeks of
conventional
physical therapy
alone in the early
and late
treatment groups.

Kwon6
(2015)

RCT

92

4-10

Diagnosis of CP, body
weight <35 kg, and age
between 4 and 10
years.

Botulinum toxin
injection within
6 months, having a
selective dorsal
rhizotomy or
orthopedic
surgery within 1 year,
displaying severe
intellectual
disability, uncontrolled
seizures, or
displaying poor visual
or hearing acuity.

1

30 min of private
hippotherapy
twice a week for
8 weeks (16
sessions), in
addition to
conventional
physical therapy
vs control group:
30 min twice a
week of home
aerobic therapy
with
conventional
physical therapy
for 8 weeks.

BOCKIUS | HIPPOTHERAPY CEREBRAL PALSY

5

joint range of motion to manually evaluate the passive movements’ resistance. 1 Deutz et al. and
Kwon et al. both used the Gross Motor Function Measure 66 (GMFM-66) to assess the
outcomes.5,6 The GMFM-66 is a subset of the original GMFM-88 which consists of 88 items
observed by a clinician from five dimensions: (A) lying and rolling; (B) sitting; (C) crawling and
kneeling; (D) standing; and (E) walking, running, and jumping.6 An increase in score for both
the GMFM-66 and the MAS indicates improvement in gross motor function.
RESULTS
Lucena-Antón et al.1 conducted a randomized control trial to evaluate the effect
hippotherapy with conventional physical therapy compared to conventional physical therapy
alone has on gross motor function through the measurement of hip adductor spasticity. Children
between the ages of 3 and 14 with spastic cerebral palsy were chosen from a group receiving
physical therapy treatment in a Rehabilitation Center for Cerebral Palsy.1 44 children completed
all assessments and were included in the study.1 A simple randomization by EPIDAT software
was done by an independent researcher who revealed to the participants their assignments (22
participants in each group).1 Due to the nature of the study, the participants could not be blind to
their treatment group.1 The intervention group received 45 minutes of hippotherapy once a week
for 12 consecutive weeks along with twice weekly conventional physical therapy.1 The
hippotherapy consisted of bareback riding with the therapist in charge of the constant speed of
the horse and positioning of the child, focusing on postural support and neutral body and pelvis
alignment.1 The control group received only the twice weekly conventional therapy.1
All participants completed the intervention and measurements.1 No adverse effects were
reported.1 Hip adductor spasticity was measured using the Modified Ashworth Scale (MAS) by
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the same blinded examiner at the same time (first one week prior to the intervention and again
one week after the intervention concluded).1 A paired t-test was performed to measure the
difference between baseline and post-therapy scores.1 A t-test for independent samples was used
to test the differences between each group.1 The mean MAS score of the left adductors changed
-0.05 in the control group and -0.27 from baseline in the intervention group.1 The mean MAS
score of the right adductors changed -0.09 in the control group and -0.45 from baseline in the
intervention group.1 MAS scores decreased in both groups, but mean changes in the intervention
group were significantly higher than the control group (p<0.05).1 A summary of the resultant
values from this study are shown in Table 2 below.
Table 2. Changes in MAS Score1
Control

Treatment

Between groups

Mean change
from baseline

Paired t test
p-value

Mean change
from baseline

Paired t test
p-value

Independent t
test p-value

Left
adductors

-0.05

0.329

-0.27

0.011

0.040

Right
adductors

-0.09

0.162

-0.45

0.009

0.047

Deutz et al. conducted a randomized, open-label, 2 x 2 (two periods, two treatments)
crossover trial investigating the effects of hippotherapy on gross motor function in children
between the ages of 5 and 16 with bilateral spastic cerebral palsy.5 Two intervention periods of
16 to 20 weeks of once to twice weekly hippotherapy in addition to their usual conventional
physical therapy were separated between a washout period of 16 weeks.5 Seventy-three children
were randomized to an early (n=35) or a late (n=38) treatment group.5 Early treatment phase
(ETP): Members of the early treatment group (ETG) received 16 to 32 units of hippotherapy
along with their conventional physical therapy, at the same time the late treatment group (LTG)
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members received only their conventional physical therapy.5 This was followed by a 16 week
washout period where all participants received their baseline physical therapy alone.5 Late
treatment phase (LTP): LTG then received 16 to 32 units of hippotherapy along with their
conventional physical therapy while the ETG received their conventional physical therapy
alone.5 A clinical investigation including GMFM-66 assessments were made prior to the ETG
intervention (E1), as well as follow-up clinical investigations after the ETG intervention (E2),
after the 16 week washout period (E3), and again after the LTG intervention (E4).5 An additional
8 weeks of observation of both groups was done followed by a final clinical investigation (E5).5
Due to the nature of the study, blinding of the participants was not possible, but the physical
therapists performing the GMFM-66 assessment were blind to the status of the children.5
There were 11 drop outs in the ETG and 8 in the LTG.5 During hippotherapy, a child fell
from a horse resulting in a humerus fracture, but no further adverse effects were noted.5 The
statistical data were presented as the mean change from baseline between no hippotherapy and
hippotherapy, standard deviation, and p-value.5 The mean between no hippotherapy and
hippotherapy intervention for the ETG was +2.99, and for the LTG was +1.60.5 A significant
improvement during hippotherapy with regard to GMFM dimension E (ability to walk, run and
jump) was found (p-value<0.05).5 A summary of the resultant values are shown in Table 3 below.
Table 3. Changes in GMFM-66 Score in Regards to Dimension E5
Group

Period

Mean

SD

ETG

HT (hippotherapy)

2.81

7.18

No HT

-0.18

3.45

No HT

-0.53

5.49

HT

1.07

3.05

Mean b/t no HT
and HT

p-value (direct
treatment effect)

+2.99

LTG

0.0268
+1.60
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Kwon et al. conducted a trial of participants consisting of 92 children with cerebral palsy
between the ages of 4 and 10 with variable levels of gross motor functioning.6 An independent
statistician performed the randomization of group placement using a computer-generated random
blocks of 2 or 4.6 One child in the hippotherapy intervention group dropped out so there were 45
children in the intervention group and 46 in the control group for the final analysis.6 Children in
the hippotherapy intervention received 30 minutes of private hippotherapy twice a week for 8
weeks along with their conventional physical therapy.6 Children in the control group received 30
minutes of home-based aerobic exercise (walking or cycling) twice a week for 8 weeks along
with their conventional physical therapy.6 The primary outcome measured was the GMFM-88
that was administered before and after the 8 week trial by the same blind examiner.6 GMFM-66
scores were calculated from the GMFM-88 using the Gross Motor Ability Estimator. 6
Data were analyzed using paired t-tests to compare changes from baseline to post
intervention between groups.6 Changes in outcome measures between groups were assessed
using independent t-tests.6 GMFM-66 scores increased significantly in the hippotherapy group
(p<0.05).6 Though, no significant change was seen in the control group from baseline (p>0.05).6
Changes in the GMFM-66 scores significantly differed between the hippotherapy and control
groups (p<0.05).6 The hippotherapy intervention group had a mean change from baseline of
+2.7.6 The results are summarized in Table 4 below.
Table 4. Changes in GMFM Between Hippotherapy and Control Groups6

GMFM-66

Hippotherapy Intervention

Control Group

P-value for
difference b/t groups

Mean change
from baseline

p-value

Mean change from
baseline

p-value

+2.7

<0.01

+0.4

0.26

<0.01
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DISCUSSION
For many children with cerebral palsy, physical therapy is a long term and extensive part
of their treatment plan. Hippotherapy is a stimulating and interactive form of physical therapy for
children with cerebral palsy. Hippotherapy provides more than just physical benefits for children
with cerebral palsy, though. There are psychological benefits such as increased confidence,
independence, and sportsmanship.7 A child with cerebral palsy, who may not have the motor
skills and coordination to participate in most sports, can experience sitting up high upon a horse’s
back while it trots and runs; a feeling they may have never gotten the chance to experience
themselves. The child also has the chance to build relationships with the trainer, the horse, and
possibly other children. The child learns how to interact with the horse or pony and even may
learn the horse’s unique personality. The child learns to communicate with the horse and
becomes emotionally connected.
There are barriers to hippotherapy treatment. Horses are large animals that require a great
deal of care and space, preventing hippotherapy from being widely accessible. Also, the horses
need to be properly trained in order to allow these young children to ride them. Hippotherapy is
considered a form of physical, occupational, and speech therapy in which the therapist directs
the horse’s movements, providing motor and sensory input to the rider. Hippotherapy costs
around $80-$115 per session. Some insurance companies will cover hippotherapy when it is
prescribed by a provider, but many will not. For example, Aetna, the third largest health
insurance company in 2021, still considers hippotherapy experimental and investigational
because there is insufficient scientific data in the peer reviewed medical literature to support the
effectiveness of hippotherapy in individuals with cerebral palsy, as well as numerous other
disorders.8
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All three studies found significant improvement in gross motor function after
hippotherapy intervention, with a substantial mean change from baseline with statistically
significant p-values. All three studies did have limitations. The participants could not be blinded
to their treatment group which could allow for either conscious or unconscious bias by the child
during their assessment by the blinded examiner. All three studies showed the short term effects
of hippotherapy, and Deutz et al. assessed the effects 8 weeks after the intervention concluded,
but none studied the long term effects. In Deutz et al., the 16 week washout period in the ETG
may have been sufficient time to lose some of the benefits of hippotherapy such as strength, but
other skills such as muscle learning, communication and confidence may persist. This could
interfere with the validity of the data when comparing the ETG to the LTG control periods.
Hippotherapy is considered an adjunct therapy so all three studies had the children
participate in their conventional physical therapy along with hippotherapy. Therefore, these
studies could not evaluate the sole effect of hippotherapy on motor function because it did not
control for the participants’ other therapeutic activities. Therapists did not completely supervise
conventional physical therapy or aerobic exercises performed by the control group. Furthermore,
in Lucena-Anton, the intervention group received three weekly sessions while the control group
only received two sessions per week. There was no attempt to replace the additional
equine-based physical therapy session each week that the intervention group received, making it
again difficult to determine if the effect is solely due to hippotherapy or the additional session
each week.
There was an appropriately large sample size in the studies conducted by Lucena-Anton
et al. and Kwon et al. Although, in the study conducted by Deutz et al., there was a 29% drop-out
rate, which brought the group size for each treatment below 30, making it difficult to generalize
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those results to all children with CP. Overall though, the inclusion criteria was an adequate
representation of children with CP and could be generalized to those who would be appropriate
candidates for hippotherapy. Lucena-Antón et al. only included non-walking children with CP
which prevents the statistics from being applied generally to all children with CP.
CONCLUSION
The evidence found in this systematic review shows that hippotherapy is effective in
improving gross motor function in children with cerebral palsy. Lucena-Antón et al., Deutz et al.,
and Kwon et al., all found statistically significant improvement in gross motor function in the
intervention group compared to the control group. Improved gross motor function can allow for
children with cerebral palsy to become more independent, especially through greater gait
stability and control of movements.
While two of the three studies specifically included kids with spastic cerebral palsy,
future studies could be done focusing on the effect of hippotherapy on gross motor function in
children with different types of cerebral palsy, such as dyskinetic or ataxic. In addition, there is a
fairly large age gap in these studies, ranging from toddlers with immature and actively
developing motor skills to pubescent adolescents in their early teens. Future studies could be
done to study the possible benefit of starting hippotherapy in early childhood versus at school
age or adolescence.
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